ID   BGAC_BIFAA              Reviewed;        1049 AA.
AC   A1A3T0;
DT   29-SEP-2021, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 1.
DT   03-AUG-2022, entry version 89.
DE   RecName: Full=Beta-galactosidase BgaC {ECO:0000303|PubMed:33427933};
DE            Short=Beta-gal {ECO:0000305};
DE            EC=3.2.1.23 {ECO:0000269|PubMed:33427933};
DE   AltName: Full=Lactase {ECO:0000305};
GN   Name=bgaC {ECO:0000303|PubMed:33427933};
GN   OrderedLocusNames=BAD_1582 {ECO:0000312|EMBL:BAF40363.1};
OS   Bifidobacterium adolescentis (strain ATCC 15703 / DSM 20083 / NCTC 11814 /
OS   E194a).
OC   Bacteria; Actinobacteria; Bifidobacteriales; Bifidobacteriaceae;
OC   Bifidobacterium.
OX   NCBI_TaxID=367928;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15703 / DSM 20083 / NCTC 11814 / E194a;
RA   Suzuki T., Tsuda Y., Kanou N., Inoue T., Kumazaki K., Nagano S., Hirai S.,
RA   Tanaka K., Watanabe K.;
RT   "Bifidobacterium adolescentis complete genome sequence.";
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND BIOTECHNOLOGY.
RC   STRAIN=ATCC 15703 / DSM 20083 / NCTC 11814 / E194a;
RX   PubMed=33427933; DOI=10.1007/s00253-020-11084-y;
RA   Mulualem D.M., Agbavwe C., Ogilvie L.A., Jones B.V., Kilcoyne M.,
RA   O'Byrne C., Boyd A.;
RT   "Metagenomic identification, purification and characterisation of the
RT   Bifidobacterium adolescentis BgaC beta-galactosidase.";
RL   Appl. Microbiol. Biotechnol. 105:1063-1078(2021).
CC   -!- FUNCTION: Catalyzes efficient hydrolysis of lactose. Also exhibits
CC       transglycosylation activity to produce oligosaccharides at low
CC       concentrations of glucose. In vitro, acts on the synthetic chromogenic
CC       substrate ortho-nitrophenyl-beta-D-galactopyranoside (ONPG). Acts
CC       exclusively on terminal beta-linked Gal residues.
CC       {ECO:0000269|PubMed:33427933}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of terminal non-reducing beta-D-galactose residues
CC         in beta-D-galactosides.; EC=3.2.1.23;
CC         Evidence={ECO:0000269|PubMed:33427933};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:33427933};
CC       Note=Mg(2+) enhances the activity by 30%, followed by Ca(2+) and then
CC       Zn(2+). {ECO:0000269|PubMed:33427933};
CC   -!- ACTIVITY REGULATION: Activity is inhibited by EDTA. Activity is
CC       abolished by Cu(2+) and shows 59% reduction in the presence of Mn(2+)
CC       (PubMed:33427933). Lactose acts as a competitive inhibitor
CC       (PubMed:33427933). {ECO:0000269|PubMed:33427933}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.7 mM for lactose {ECO:0000269|PubMed:33427933};
CC         KM=2.5 mM for ONPG {ECO:0000269|PubMed:33427933};
CC         Vmax=22 umol/min/mg enzyme with lactose as substrate
CC         {ECO:0000269|PubMed:33427933};
CC         Vmax=107 umol/min/mg enzyme with ONPG as substrate
CC         {ECO:0000269|PubMed:33427933};
CC       pH dependence:
CC         Optimum pH is 7.0 with ONPG as substrate. Retains 60% of its activity
CC         between pH 6.0 and 8.0. {ECO:0000269|PubMed:33427933};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius with ONPG as substrate.
CC         Retains 60% of its activity between 20 and 45 degrees Celsius.
CC         {ECO:0000269|PubMed:33427933};
CC   -!- BIOTECHNOLOGY: Possesses the industrially desirable properties of high
CC       substrate affinity for lactose and low product inhibition by galactose,
CC       and is an ideal candidate for dairy industry applications and prebiotic
CC       manufacture. {ECO:0000269|PubMed:33427933}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP009256; BAF40363.1; -; Genomic_DNA.
DR   RefSeq; WP_011743877.1; NC_008618.1.
DR   SMR; A1A3T0; -.
DR   STRING; 1680.BADO_1688; -.
DR   CAZy; GH2; Glycoside Hydrolase Family 2.
DR   EnsemblBacteria; BAF40363; BAF40363; BAD_1582.
DR   KEGG; bad:BAD_1582; -.
DR   HOGENOM; CLU_002346_0_2_11; -.
DR   OMA; HPEYTIT; -.
DR   Proteomes; UP000008702; Chromosome.
DR   GO; GO:0009341; C:beta-galactosidase complex; IEA:InterPro.
DR   GO; GO:0004565; F:beta-galactosidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016052; P:carbohydrate catabolic process; IEA:UniProt.
DR   Gene3D; 2.60.40.10; -; 2.
DR   Gene3D; 2.70.98.10; -; 1.
DR   InterPro; IPR004199; B-gal_small/dom_5.
DR   InterPro; IPR036156; Beta-gal/glucu_dom_sf.
DR   InterPro; IPR011013; Gal_mutarotase_sf_dom.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR014718; GH-type_carb-bd.
DR   InterPro; IPR006101; Glyco_hydro_2.
DR   InterPro; IPR006103; Glyco_hydro_2_cat.
DR   InterPro; IPR023230; Glyco_hydro_2_CS.
DR   InterPro; IPR006102; Glyco_hydro_2_Ig-like.
DR   InterPro; IPR006104; Glyco_hydro_2_N.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR032312; LacZ_4.
DR   Pfam; PF02929; Bgal_small_N; 1.
DR   Pfam; PF16353; DUF4981; 1.
DR   Pfam; PF00703; Glyco_hydro_2; 1.
DR   Pfam; PF02836; Glyco_hydro_2_C; 1.
DR   Pfam; PF02837; Glyco_hydro_2_N; 1.
DR   PRINTS; PR00132; GLHYDRLASE2.
DR   SMART; SM01038; Bgal_small_N; 1.
DR   SUPFAM; SSF49303; SSF49303; 2.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   SUPFAM; SSF74650; SSF74650; 1.
DR   PROSITE; PS00719; GLYCOSYL_HYDROL_F2_1; 1.
PE   1: Evidence at protein level;
KW   Glycosidase; Hydrolase; Magnesium; Metal-binding; Reference proteome.
FT   CHAIN           1..1049
FT                   /note="Beta-galactosidase BgaC"
FT                   /id="PRO_0000453260"
FT   ACT_SITE        483
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   ACT_SITE        557
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   BINDING         430
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   BINDING         432
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   BINDING         483
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   SITE            371
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
FT   SITE            405
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P00722"
SQ   SEQUENCE   1049 AA;  116448 MW;  44D9307C3E31C39D CRC64;
     MADTAELAIV HATTASASWL TDPTVFAANR KPAHSSHRYV IGETREPKQS LDGEWKVRIE
     QARNVDVESA PFAAVDFEDG DFGAIEVPGH LQMAGYLKNK YVNIQYPWDG HEDPQAPNIP
     ENNHVAIYRR RFALDAQLAR TLENDGTVSL TFHGAATAIY VWLDGTFVGY GEDGFTPSEF
     DVTEALRNGN GNAADSPEAE HTLTVACYEY SSASWLEDQD FWRLHGLFRT VELAAQPHTH
     VETVQLEADY TAADTAGTAD TAELNAALTL RNPADAMTIE STLRDGDGNV VWESTQACNG
     EIALNSGKMT NIAPWSAESP TLYTLTVRVV GHDGAIIETV TQKIGFRTFR IENGIMTING
     KRIVFKGADR HEFDAKRGRA ITREDMLSDV VFCKRHNINA IRTSHYPNQE YWYDLCDEYG
     LYLIDETNME THGTWVANNV ERPEDGIPGS RPEWEGACVD RINSMMRRDY NHPSVLIWSL
     GNESSAGEVF RAMYRHAHTI DPNRPVHYEG SVHMREFEDV TDIESRMYAH ADEIERYLND
     GSPAHTDGPK KPYISCEYMH AMGNSCGNMD EYTALERYPM YQGGFIWDFI DQAIETKLPD
     GTTRMCYGGD FGDRPSDYEF SGDGLLFADR TPSPKAQEVK QLYANVKIAV SVDEARITND
     NLFVSTGDYR FVLRILADGK PVWSTTRRFD VAAGESASFE VDWPVDDYRS NAEELVLEVS
     QQLGNACDWA PAGYELAFGQ CVVAGAKTTA DAVDAAGAPA DGTVTLGRWN AGVRGQGREA
     LFSRTQGGMV SYTFGEREFV LRRPSITTFR PLTDNDRGAG HAFERAAWAV AGKYARCVDC
     AIANRGENAV EATYTYELAI PQRTKVTVRY VADTAGLVSL DVEYPGEKNG DLPTIPAFGI
     EWALPVEYAN LRFYGAGPEE TYADRRHAKL GVWSTTAGDD CAPYLLPQET GNHEDVRWAE
     ITDDSGHGVR VKRGAGAKPF AMSLLPYSST MLEEALHQDE LPKPRHMFLR LLAAQMGVGG
     DDSWMSPVHE QYQLPADQPL SLNVQLKLF
//
